絞り込み

16530

広告

Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids.

著者 Park JW , Curtis JR , Moon J , Song YW , Kim S , Lee EB
Ann Rheum Dis.2017 Nov 01 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (27view , 0users)

Full Text Sources

Miscellaneous

To investigate the efficacy and safety of trimethoprim/sulfamethoxazole (TMP-SMX) as primary prophylaxis for pneumocystis pneumonia (PCP) in patients with rheumatic diseases receiving high-dose steroids.
PMID: 29092853 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード